NEK2 and head and neck carcinoma: Because we reported that NEK2 was highly expressed in the head and neck carcinoma, we further compared two public GEP datasets for NPC and normal nasopharyngeal epithelia control (NC) including 41 (10 NC and 31 NPC) and 28 (3 NC and 25 NPC) cases, respectively.